Thursday, 20 July 2017

Agilent Technologies presents Thought Leader award to Professor Dwight Stoll

20 April 2017 | News | By BioSpectrum Bureau

Agilent Technologies presents Thought Leader award to Professor Dwight Stoll

Agilent Technologies Inc. announced that Prof. Dwight Stoll has received an Agilent Thought Leader Award in support of his research applying two-dimensional liquid chromatography (2D-LC) to biopharmaceutical analysis.

An influential researcher in chromatography, Prof. Stoll specializes in multi-dimensional separations, which enables scientists to isolate the components of complex samples with greater ease and clarity.

"I am honored to receive this award, and very excited about Agilent's support of the vision of my laboratory and our collaborators, as we focus on the development of next-generation analytical tools based on 2D-LC for the biopharmaceutical research area," said Prof. Stoll, associate professor of analytical chemistry at Gustavus Adolphus College in Saint Peter, Minnesota.

Prof. Stoll will lead a project on the use of 2D-LC in biopharmaceutical analysis that includes several international experts: Prof. Michael Lämmerhofer of the University of Tuebingen, Germany; Dr. Douglas Richardson of Merck Research Laboratories, Kenilworth, NJ, USA; and Dr. Davy Guillarme of the University of Geneva, Switzerland.

"We are pleased to support Dr. Stoll's research using Agilent's transformative 2D-LC technology, which has the potential to resolve key challenges that biopharmaceutical scientists face when analyzing complex samples," said Dr. Stefan Schuette, vice president and general manager Liquid Phase Separations Division at Agilent Technologies. "The collaborative nature of the research of Dr. Stoll and his international colleagues, combining both academia and industry, will undoubtedly accelerate the progress of these types of solutions for the biopharma industry."

Schuette noted that the high separation power of Agilent's 2D-LC technology makes it ideal for the analysis of highly complex biopharmaceuticals, whether used for comprehensive screening or detailed determination of specific peptides.

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account

Survey Box

Is value- based patient healthcare system more effective in Asian countries?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls